Login / Signup

Ixazomib-based induction regimens plus ixazomib maintenance in transplant-ineligible, newly diagnosed multiple myeloma: the phase II, multi-arm, randomized UNITO-EMN10 trial.

Roberto MinaAntonietta Pia FalconeSara BringhenAnna Marina LiberatiNorbert PescostaMaria Teresa PetrucciGiovannino CicconeAndrea CapraFrancesca PatriarcaDelia Rota-ScalabriniFrancesca BonelloCaterina MusolinoMichele CeaRenato ZambelloPaola TacchettiAngelo BelottiClaudia CelliniLaura ParisMariella GrassoSara AquinoLorenzo De PaoliGiovanni De SabbataStelvio BallantiMassimo OffidaniMario BoccadoroFederico MonacoPaolo CorradiniAlessandra Larocca
Published in: Blood cancer journal (2021)
Keyphrases
  • phase ii
  • newly diagnosed
  • multiple myeloma
  • open label
  • clinical trial
  • phase iii
  • placebo controlled
  • double blind
  • study protocol
  • randomized controlled trial